Sanaria Inc.
Nafijah Khan is a seasoned finance professional with extensive experience in various leadership roles. Currently serving as the Vice President of Finance at Sanaria Inc. since 2022, Nafijah manages financial presentation to the board, oversees full-cycle accounting, and handles multiple funding sources. Previous experience includes serving as Financial Controller at Lessard Design Inc. for a brief tenure in 2021, where daily financial operations and internal controls were supervised, and as Chief Financial Officer at Michael Marshall Design from 2014 to 2020, focusing on risk mitigation and financial reporting accuracy. Nafijah's accounting career began as a Junior Accountant at APEX 2000, INC., progressing through roles such as Staff Accountant and Senior Accounting Consultant. Educational credentials include an MBA from Georgetown University and a B.S. in Accounting from George Mason University.
This person is not in any teams
Sanaria Inc.
Sanaria is a biotechnology company dedicated to the production of a vaccine protective against malaria caused by the pathogen Plasmodium falciparum. Sanaria’s vaccine is based on an approach to immunization that has already proven highly protective in humans.